Clinical Trials Directory

Trials / Unknown

UnknownNCT03361202

Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium

Evolution of Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium With Prosthesis (Amplatzer® Cardiac Plug)

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Institut Mutualiste Montsouris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare levels of differnts types of microparticles circulating before and after percutaneous occluding of the left atrium by patients with atrial fibrillation and patients control. Hypothesis is that prothesis implantation will decrease levels of microparticles circulating in blood circulation because of occluding of the left atrium .

Conditions

Interventions

TypeNameDescription
OTHERblood sampling* atrial fibrillation group:before Percutaneous Occluding of the Left Atrium, at hospital discharge and at J45 follow up * control group:before coronary angiography and at hospital discharge.

Timeline

Start date
2015-01-01
Primary completion
2018-01-01
Completion
2018-03-01
First posted
2017-12-04
Last updated
2017-12-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03361202. Inclusion in this directory is not an endorsement.